Pfizer's profit plummets

Published November 1, 2016 3 Plays

Rumble The U.S.' largest drugmaker scaled back its profit outlook for the year and said it's stopping development of the cholesterol drug, bococizumab. Fred Katayama reports.

0 COMMENTS